Use the National Center for Complementary and Integrative Health (NCCIH) Informed Consent Document Template and Guidelines, as a template to complete an Informed Consent form for the Phase II, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TJ301 (FE 999301) Administered Intravenously in Patients with Active Ulcerative Colitis protocol.
Please take an opportunity to read the informed consent template, page 2 which states the following:
“For the purposes of this document, guidelines within the template will be provided in italics. If this document is used to develop your informed consent form, please remember to delete the italicized instructions and insert your specific information.”
Please cite your work